Interferons are cellular glycoproteins that inhibit viral replication and that may be involved in the defensive response of an animal to virus infection. Virus infection of cells induces the synthesis and release of interferons, which render uninfected cells resistant to virus infection. Interferon can be induced by agents other than viruses, such as micro-organisms (1), substances of microbial origin (2) , and synthetic polymers (3) . Although interferon is not specific for a particular virus, it displays a characteristic cell specificity, being more active on homologous than on heterologous cells. Interferons not only display antiviral activity, but also have been shown to affect various cellular mechanisms that are not directly related to viral replication. Interferons inhibit cell growth (4), facilitate or suppress interferon i~duction (priming and blocking effects) (5, 6) , and increase the susceptibility of cells to the toxicity of double-stranded RNAs (7) . Moreover, they affect several immunological functions: interferons inhibit antibody formation in vivo and in vitro (8, 9) , and enhance the phagocytic activity of macrophages (10) , the cytotoxicity of lymphocytes (11) (12) (13) , and IgE-mediated histamine release from basophils (14) .
Exposure of lymphocytes to viruses induces the release of interferon molecules that can be distinguished immunologically from the interferon produced by other cell types (15) . The synthesis of interferon from lymphocytes can also be induced by immune stimulation (bacterial [16] and viral antigens [17] [18] [19] , alloantigens [20] ), anti-lymphocyte sera (21) , and mitogenic lectins (22) .
We have recently described that viral inhibitors are released in the supernates of mixed cultures of lymphocytes and certain tumor-derived or virustransformed cell cultures (23) . In the present study we identify these inhibitors as the reciprocal of the highest dilution inhibiting 50% of the cytopathic effect. Each assay included a standard interferon preparation (NIH human Reference Interferon G-023-901-527 with a titer of 20,000 U). 1 anti-viral U in our testing procedure is equivalent to approximately 1 reference U of the NIH interferon.
Mouse interferon was similarly measured on monolayers of murine L-F2 cells, by using EMC (50,000 PFU/well) as the challenge virus (35) . Assays were standardized against an NIH mouse interferon reference standard. 1 anti-viral U in this testing procedure cells is equal to 1 U of reference standard.
Leucine, Uridine, and Thymidine Uptake. 104 trypsinized cells in 0.1 ml RPMI-FBS were added to flat bottom wells of microtiter plates (3040, Falcon), and 0.1 ml of dilutions of the supernates to be tested were added to triplicate wells. The cells were incubated for 18 h at 37°C, then 2 ~Ci of [3H]labeled precursors (New England Nuclear Corp., Boston, Mass.) were added to each well. The cells were incubated for another 6 h, then the medium was removed, 0.2 ml of trypsin (0.25%) was added, and the cells were collected on to glass fiber filters (GF/B, Whatman, Inc., Clifton, N. J.) by means of a semi-automatic collector (O. Hiller, Madison, Wis.). Radioactivity was assessed by liquid scintillation spectrometry.
[3H]thymidine uptake inhibitory units are defined at the reciprocal of the dilution inhibiting 50% [3H]thymidine uptake in rhabdomyosarcoma (RDMC) cells.
Results

Anti-Viral Activity in the Supernates of Mixed Cultures.
The results obtained by testing for presence of anti-viral activity in the supernates of mixed cultures of human lymphocytes with cells obtained from fibroblast, virus-transformed, tumor-derived, and lymphoid cell lines are summarized in Table I . No anti-viral activity was usually observed in the supernates from human lymphocytes cultured alone. None of the 13 human fibroblast cultures tested induced anti-viral activity when mixed with human lymphocytes, whereas 13 out of 21 tumor-derived cell lines were inductive. The association between the tumor origin of a line and its ability to induce interferon was highly significant (P = 0.00022, Fisher's exact test). None of the cell lines, including the lymphoid lines, spontaneously released detectable anti-viral activity when cultured alone under conditions comparable to those of the mixed cultures. Moreover, the supernates from inducer cell lines, which included one EBV-and two SV40-producing lines, were unable to stimulate human lymphocytes to produce the virus inhibitor(s). Table II summarizes the results of culturing murine cells from several different lines with human lymphocytes or with mouse spleen cells. The supernate from BALB/c spleen cells cultured alone usually contained 1-2 U of anti-viral activity. The lines that induced anti-viral activity when cultured with human lymphocytes also induced such activity in mouse spleen cells, although the activity obtained with mouse lymphocytes was always much lower.
Allogeneic and Syngeneic Mixed Cultures. As a control in each experiment, two allogeneic human lymphocyte preparations were cultured together. When tested for anti-viral activity after a 24-h incubation, the supornates from these cultures were always negative. Lymphocytes from donor H. K., from whom the lymphoid line HK was established by transformation of peripheral blood lymphocytes with Epstein-Barr virus (EBV), were able to produce anti-viral activity when mixed with autologous HK cells. When spleen cells from C57BL/6 or BALB/c mice were cultured with cells from lines able to induce interferon production in human lymphocytes, anti-viral activity was detected in the supernate of xenogeneic, allogeneic, and syngeneic combinations (Table III) . The anti-viralinhibitors in the supernates from mixed cultures of lymphocytes and Characterization of the Viral Inhibitor. Supernate from human mixed cultures was not toxic for human fibroblast cells. Pretreatment for 18 h at 37°C of [51Cr]labeled FS1 cells with a dilution of supernate from a mixed lymphocyte-RDMC culture containing 103 anti-viral U did not increase the spontaneous release of 51Cr from the cells (36) . The preparations containing anti-viral activity effectively inhibited viral replication at a dilution at which cellular DNA, RNA, and protein synthesis were not affected (Fig. 1) .
The anti-viral activity in the supernate of mixed human lymphocyte human cell cultures was active on FS1 cells by using different challenge viruses (NDV, EMC, vaccinia virus, and influenza A (H3N2) virus).
The viral inhibitor in the supernate did not inhibit virus replication when The viral inhibitor was completely destroyed by treatment of diluted supernate with 0.1 mg/ml of trypsin (1 h incubation at 37°C). After gel filtration of concentrated supernate on a Sephade:~ G100 fine column, the anti-viral activity was recovered in two peaks of apparent mol wt of approximately 45,000 and 25,000 daltons (Fig. 2) . In some experiments, a variable amount of activity was in front of the albumin peak. Chromatography of NDV-induced lymphocyte interferon (obtained after treatment at pH 2.0) gave only one peak of anti-viral activity with reel wt 25,000. When NDV interferon was not pretreated at pH 2.0, the same two peaks (45,000 and 25,000) were obtained. The anti-viral activity in the 25,000 peak was resistant to treatment at pH 2.0, whereas the activity in the 45,000 peak was destroyed under the same conditions.
The above characterization of the viral inhibitor in the supernates of mixed cultures allows their acceptance as interferons.
Characterization of the Human Lymphocyte Population Producing Inferferon.
Human lymphocytes, preincubated at 22°C for a period of up to 24 h, maintained the ability to produce interferon when induced by RDMC cells in mixed culture or by infection with NDV. In contrast, after 17 h ofpreincubation at 37°C, the lymphocytes were unable to be induced by RDMC cells, but still responded to NDV infection with an anti-viral activity reduced to about 20% of that observed with fresh cells.
The results of experiments with cell fractions of the lymphocyte population are presented in Table IV . Depletion of glass-adherent cells from Ficoll-Hy- 
paque-separated lymphocytes increased the level of anti-viral activity obtained by induction with RDMC cells (Exp A)
. The major population responsible for interferon production in mixed cultures of lymphocytes and RDMC cells was not adherent to nylon fiber columns, did not form rosettes with AET-treated sheep erythrocytes, and was retained on an Ig-anti-IgG column. The cell fractions in Exp. C of Table IV were all incubated with erythrocytes and subjected to hypo-osmotic treatment to avoid artifactual results due to different handling of the subpopulations. 5 ). About 500 anti-viral U were required to inhibit 50% uptake in RDMC cells (Figs. i b and 3) . In gel filtration experiments the activity inhibiting thymidine incorporation was eluted in the same two peaks of the anti-viral activity.
Anti-Cellular
Inhibition of Cell Growth. Supernates from mixed cultures of lymphocytes and cells from RDMC or other interferon-inducing lines were able to inhibit cell growth in different human cell lines (Fig. 4) . This effect was detected only when supernate was used in concentrations containing more than 500 anti-viral U. The supernate from lymphocytes cultured alone or from RDMC cells cultured alone had no significant effect (Fig. 4) . (40) for acceptance of a viral inhibitor as an interferon: (a) it is a protein that is readily destroyed by incubation with trypsin; (b) it does not inhibit viral replication through a toxic effect on the cells; (c) it is active against all viruses tested; (d) it does not directly inactivate the virus; instead it induces an anti-viral status in the cells that persists when the inhibitor is removed from the medium; synthesis by the cells of both RNA and protein are required for induction of the anti-viral status. In addition, the viral inhibitor shows other properties that are common to most interferons: it is more active in homologous than heterologous cells; it is not released spontaneously but only in the presence of the inducer cell line; one of the two molecular populations identified by gel filtration is stable at pH 2.0.
The gel filtration experiments show that at least two molecular species of interferon are present in the supernate of the mixed cultures. The viral inhibitor which elutes in a peak corresponding to a mol wt approximately 25,000 represents the majority of the activity. This interferon is stable at pH 2.0, and is probably corresponding to the type I interferon of Youngner and Salvin (41) . Type I interferon in the mouse is produced by cells other than T cells and can be induced by viruses and by B-cell stimulants (41, 42) . In humans, NDV-induced leukocyte interferon (43, and our results) also has a mol wt of approximately 25,000. The viral inhibitor in the supernate of mixed cultures, which is eluted with a peak of approximately 45,000, is unstable at pH 2.0 and shares most of the characteristics of the interferon designed as type II (41) or immune (44) interferon. In the mouse, this type of interferon is considered to be a product of T cells activated mainly by antigenic or mitogenic stimulation (42, 44) . However, we have found some anti-viral activity in a peak corresponding to a mol wt of 45,000 after gel filtration of NDV-induced interferon that had not been pretreated at pH 2.0. We have also found the presence of a variable amount of antiviral activity eluting in front of the albumin peak possibly due to molecules of interferons that bind to albumin or other proteins (45) .
Cell separation experiments have been performed to identify the population of human peripheral blood lymphocytes necessary for interferon production in the mixed cultures. Monocytes are not only unnecessary for interferon production in mixed cultures but also have an inhibitory effect. Depletion of B cells (surface immunoglobulin-bearing cells) and monocytes by incubation on nylon fiber columns increased interferon production by the eluted cell population. The B-cell-enriched populations recovered from the columns produced very little interferon. On the other hand, lymphocytes depleted of both surface immunoglobulin-bearing cells and Fc-receptor-bearing cells (on IgG-anti-IgG columns) were capable of producing only minimal amounts of interferon in the mixed culture experiments. These data suggest that the major effector cell population is composed of lymphocytes without surface immunoglobulins but with Fcreceptors. To evaluate the role of T cells in the production of interferon we employed AET-treated sheep erythrocytes, reported to be the most sensitive for rosetting techniques (38) . When corrected for the different numbers of cells recovered in the two populations (usually 4-10 times more cells in the rosetting fraction), the data indicate that most of the interferon-producing lymphocytes do not bind to AET-treated sheep erythrocytes. These results exclude a major role of T cells in the production of interferon in this system. All the lymphocyte subpopulations able to produce interferon also contained most of the activity of the natural killer cells. Natural killer cells not only spontaneously interact with and lyse inducer cells in the mixed cultures (46) , thus possibly playing some role in the induction of interferon itself, but their cytotoxic activity is also strongly enhanced by the presence of interferon in the culture (36) .
In addition to the anti-viral activity, an anti-cellular activity is present in the supernate of mixed human lymphocyte human cell cultures. The major effect on cellular metabolism is inhibition of DNA synthesis, as measured by inhibition of [3H]thymidine uptake. That this assay actually measures inhibition of DNA synthesis and not an artifactual inhibition of the uptake of the labeled precursor, as observed with supernate from macrophage and lymphocyte cultures (47, 48) , is suggested by these facts: the inhibitory activity is not dialyzable and it inhibits cell proliferation. Although a close correlation between anti-cellular and anti-viral activity has been observed in the present experiments, as in several other studies with virus-induced interferon (49) (50) (51) (52) , no conclusion can be derived on the unsettled issue of whether or not the anticellular and the anti-viral activities in interferon preparations are mediated by the same molecules (45, (49) (50) (51) (52) (53) .
The characteristics that make certain cell lines able to induce interferon and the nature of the stimulus that triggers the lymphocytes are still unknown (23) . Although the association of ability to induce interferon with transformation by EBV or mouse sarcoma virus or with the tumor origin of the line is statistically significant, any speculation on the biological relevance of such an association seems premature. That stimulation by allogeneic (or heterologous) antigens are responsible for stimulation may be excluded by the induction of interferon in autologous or syngeneic mixed cultures, both in human and in the mouse.
The possibility that viruses present in the cell lines are directly responsible for the induction seems to be unlikely. The possibility remains that some viruses usually associated with inducer cell lines (murine sarcoma virus, EBV), unknown viruses or other agents derived from the original tumor or acquired in culture induce particular antigenic or structural surface characteristics that are responsible for the interaction with the lymphocytes and their stimulation.
It is not possible to extrapolate the data obtained in vitro with cell lines to infer a stimulation of interferon in vivo by spontaneous tumors. Indeed, a hyporeactive factor, which inhibits interferon production, is present in the serum of tumor-bearing mice (54, 55) . This factor could mask a stimulation by tumor cells. However, at least in the case of transplantable tumors in mice, our experiments and a preliminary report by others (56) show interferon induction by syngeneic tumor cells in vivo: because of the effect of interferon both on the host defense mechanisms and on the tumor cell metabolism (2) this phenomenon might affect the progress of the transplanted tumor.
Summary A viral inhibitor(s) is released in the supernate of mixed cultures containing human or mouse lymphocytes and cells from certain lines. The inhibitor is active against a variety of unrelated viruses and is a protein that is not toxic for cells. It does not inactivate viruses directly, but inhibits viral replication through an intracellular mechanism that involves synthesis by the cells of both RNA and protein. These characteristics identify the inhibitor as an interferon. The anti-viral activity is contained in at least two molecular species, of approximately 25,000 and 45,000 daltons, respectively. In addition to the antiviral activity, the supernates of the mixed cultures display an anti-cellular activity, the inhibition of DNA synthesis and of cell multiplication. The antiviral and the anti-cellular activities are positively correlated in supernates from various cultures and in partially purified preparations. The human cell population responsible for interferon production is composed mainly of Fc-receptor positive, surface immunoglobulin negative, non-T-cell lymphocytes. The ability of certain cell lines to induce interferon seems to be preferentially associated with tumor origin or with in vitro transformation by certain viruses (EpsteinBarr virus, murine sarcoma virus).
